{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T19:19:56Z","timestamp":1768936796141,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T00:00:00Z","timestamp":1550880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T00:00:00Z","timestamp":1550880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ES016774-01, AG043718, GM109091, GM103444"],"award-info":[{"award-number":["ES016774-01, AG043718, GM109091, GM103444"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"VA","award":["1I01RX001450-01A1"],"award-info":[{"award-number":["1I01RX001450-01A1"]}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","award":["15SFDRN25710468"],"award-info":[{"award-number":["15SFDRN25710468"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12035-019-1517-2","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T22:02:14Z","timestamp":1550959334000},"page":"6386-6396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["GM6 Attenuates Alzheimer\u2019s Disease Pathology in APP Mice"],"prefix":"10.1007","volume":"56","author":[{"given":"Jin","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeid","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Mondy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Kirstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Swindell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0144-2172","authenticated-orcid":false,"given":"Mark S.","family":"Kindy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,23]]},"reference":[{"key":"1517_CR1","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1056\/NEJMcp0910236","volume":"362","author":"R Mayeux","year":"2010","unstructured":"Mayeux R (2010) Clinical practice. Early Alzheimer\u2019s disease. N Engl J Med 362:2194\u20132201","journal-title":"N Engl J Med"},{"key":"1517_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM (2010) Alzheimer\u2019s disease. N Engl J Med 362:329\u2013344","journal-title":"N Engl J Med"},{"key":"1517_CR3","first-page":"5","volume":"4","author":"S Li","year":"2010","unstructured":"Li S, Shankar GM, Selkoe DJ (2010) How do soluble oligomers of amyloid beta-protein impair hippocampal synaptic plasticity? Front Cell Neurosci 4:5","journal-title":"Front Cell Neurosci"},{"key":"1517_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12017-009-8109-7","volume":"12","author":"RA Sperling","year":"2010","unstructured":"Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, LaViolette PS, Vitolo OV, Hedden T, Becker JA et al (2010) Functional alterations in memory networks in early Alzheimer\u2019s disease. NeuroMolecular Med 12:27\u201343","journal-title":"NeuroMolecular Med"},{"key":"1517_CR5","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","volume":"101","author":"DM Walsh","year":"2007","unstructured":"Walsh DM, Selkoe DJ (2007) A beta oligomers - a decade of discovery. J Neurochem 101:1172\u20131184","journal-title":"J Neurochem"},{"key":"1517_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10522-008-9162-6","volume":"9","author":"DK Lahiri","year":"2008","unstructured":"Lahiri DK, Zawia NH, Greig NH, Sambamurti K, Maloney B (2008) Early-life events may trigger biochemical pathways for Alzheimer\u2019s disease: the \u201cLEARn\u201d model. Biogerontology 9:375\u2013379","journal-title":"Biogerontology"},{"key":"1517_CR7","doi-asserted-by":"publisher","first-page":"S329","DOI":"10.1301\/nr.2007.dec.S239-S243","volume":"65","author":"DJ Selkoe","year":"2007","unstructured":"Selkoe DJ (2007) Developing preventive therapies for chronic diseases: lessons learned from Alzheimer\u2019s disease. Nutr Rev 65:S329\u2013S343","journal-title":"Nutr Rev"},{"key":"1517_CR8","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","volume":"73","author":"C Holmes","year":"2009","unstructured":"Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, Culliford D, Perry VH (2009) Systemic inflammation and disease progression in Alzheimer disease. Neurology 73:768\u2013775","journal-title":"Neurology"},{"key":"1517_CR9","first-page":"89","volume":"5","author":"RMW Chau","year":"1992","unstructured":"Chau RMW, Ren F, Huang W, Jen LS (1992) Muscle neurotrophic factors specific for anterior horn motoneurons of rat spinal cord. Recent Adv Cell Mol Biol 5:89\u201394","journal-title":"Recent Adv Cell Mol Biol"},{"key":"1517_CR10","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1360\/csb1992-37-19-1742","volume":"37","author":"MH Zhou","year":"1992","unstructured":"Zhou MH, Wu XY, Ren F, Zhao LP, Huang WQ, Yang ZY, Ren LS (1992) Effect of 22kD, 35kD molecules from skeletal muscle extract on ant. Horn motoneuron of lumbar spine in rat. Chin Sci Bull 37:1742\u20131745","journal-title":"Chin Sci Bull"},{"key":"1517_CR11","first-page":"391","volume":"24","author":"MH Zhou","year":"1993","unstructured":"Zhou MH, Yu WH, Reb F (1993) Changes in MNTF and its receptor in tongue muscle post-denervation of the hypoglossal nerve. Acta Anatomica Sin 24:391\u2013395","journal-title":"Acta Anatomica Sin"},{"key":"1517_CR12","first-page":"248","volume":"5","author":"AM Wang","year":"1995","unstructured":"Wang AM, Chau RMW, Chow SP, Zhang ZY, Li ZM (1995) Effects of myogenic 22 and 35kD neurotrophic factors on axonal regeneration in free peripheral autografts into rat spinal cord. Chin J Spine Spinal Cord 5:248\u2013252","journal-title":"Chin J Spine Spinal Cord"},{"key":"1517_CR13","unstructured":"Chau, R.M.W. 2001. Polynucleotides encoding motoneuronotrophic factors. US Patent. #6,309,877."},{"key":"1517_CR14","unstructured":"Chau, R.M.W. 2005. Methods and use of motoneuronotrophic factors. US Patent. #6,841,531."},{"key":"1517_CR15","unstructured":"Chau, R.M.W. 2007. MNTF peptides and compositions and methods of use. US patent. #7,183,373."},{"key":"1517_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.brainres.2008.08.053","volume":"1238","author":"J Yu","year":"2008","unstructured":"Yu J, Zhu H, Ko D, Kindy MS (2008) Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouse. Brain Res 1238:143\u2013153","journal-title":"Brain Res"},{"key":"1517_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK et al (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13:159\u2013170","journal-title":"Hum Mol Genet"},{"key":"1517_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.nbd.2004.10.022","volume":"18","author":"A Savonenko","year":"2005","unstructured":"Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, Price DL, Tang F et al (2005) Episodic-like memory deficits in the APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis 18:602\u2013617","journal-title":"Neurobiol Dis"},{"key":"1517_CR19","doi-asserted-by":"publisher","first-page":"7745","DOI":"10.1074\/jbc.M708362200","volume":"283","author":"VY Hook","year":"2008","unstructured":"Hook VY, Kindy M, Hook G (2008) Inhibitors of cathepsin B improve memory and reduce A beta in transgenic Alzheimer\u2019s disease mice expressing the wild-type, but not the Swedish mutant, betasecretase A\u03b2PP site. J Biol Chem 283:7745\u20137753","journal-title":"J Biol Chem"},{"key":"1517_CR20","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.4049\/jimmunol.1201904","volume":"189","author":"A Elvington","year":"2012","unstructured":"Elvington A, Atkinson C, Zhu H, Yu J, Takahashi K, Stahl GL, Kindy MS, Tomlinson S (2012) The alternative complement pathway propagates inflammation and injury in murine ischemic stroke. J Immunol 189:4640\u20134647","journal-title":"J Immunol"},{"key":"1517_CR21","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.2353\/ajpath.2008.070620","volume":"172","author":"SS El-Amouri","year":"2008","unstructured":"El-Amouri SS, Zhu H, Yu J, Gage FH, Verma IM, Kindy MS (2008) Neprilysin: an enzyme candidate to treat Alzheimer\u2019s disease. Am J Pathol 172:1342\u20131354","journal-title":"Am J Pathol"},{"key":"1517_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1515\/bc.2010.110","volume":"391","author":"V Hook","year":"2010","unstructured":"Hook V, Hook G, Kindy MS (2010) Pharmacogenetic features of inhibitors to cathepsin B that improve memory deficit and reduces beta-amyloid related to Alzheimer\u2019s disease. Biol Chem 391:861\u2013872","journal-title":"Biol Chem"},{"key":"1517_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3233\/JAD-2011-101986","volume":"25","author":"J Yu","year":"2011","unstructured":"Yu J, Gattoni-Celli M, Zhu H, Bhat NR, Sambamurti K, Gattoni-Celli S, Kindy MS (2011) Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of APP transgenic mice. J Alzheimers Dis 25:295\u2013307","journal-title":"J Alzheimers Dis"},{"key":"1517_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/JAD-131370","volume":"41","author":"G Hook","year":"2014","unstructured":"Hook G, Yu J, Toneff T, Kindy M, Hook V (2014) Brain pyroglutamate amyloid-\u03b2 is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer\u2019s disease therapeutic. J Alzheimers Dis 41:129\u2013149","journal-title":"J Alzheimers Dis"},{"key":"1517_CR25","first-page":"1","volume":"65","author":"KD Kochanek","year":"2016","unstructured":"Kochanek KD, Murphy SL, Xu J, Tejada-Vera B (2016) Deaths: final data for 2014. Natl Vital Stat Rep 65:1\u2013122","journal-title":"Natl Vital Stat Rep"},{"key":"1517_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/jnc.13632","volume":"139","author":"E Karran","year":"2016","unstructured":"Karran E, De Strooper B (2016) The amyloid cascade hypothesis: are we poised for success or failure? J Neurochem 139:237\u2013252","journal-title":"J Neurochem"},{"key":"1517_CR27","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8:595\u2013608","journal-title":"EMBO Mol Med"},{"key":"1517_CR28","doi-asserted-by":"publisher","unstructured":"Holtzman DM, Mandelkow E, Selkoe DJ (2012) Alzheimer disease in 2020. Cold Spring Harb Perspect Med 2(11). \n                    https:\/\/doi.org\/10.1101\/cshperspect.a011585","DOI":"10.1101\/cshperspect.a011585"},{"key":"1517_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12929-017-0355-7","volume":"24","author":"SY Hung","year":"2017","unstructured":"Hung SY, Fu WM (2017) Drug candidates in clinical trials for Alzheimer\u2019s disease. J Biomed Sci 24:47","journal-title":"J Biomed Sci"},{"key":"1517_CR30","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian AS, Vergallo A et al (2018) The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain 141:1917\u20131933","journal-title":"Brain"},{"key":"1517_CR31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/ana.24001","volume":"74","author":"DJ Selkoe","year":"2013","unstructured":"Selkoe DJ (2013) The therapeutics of Alzheimer\u2019s disease: where we stand and where we are heading. Ann Neurol 74:328\u2013336","journal-title":"Ann Neurol"},{"key":"1517_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pharep.2015.07.006","volume":"68","author":"J Godyn","year":"2016","unstructured":"Godyn J, Jonczyk J, Panek D, Malawska B (2016) Therapeutic strategies for Alzheimer\u2019s disease in clinical trials. Pharmacol Rep 68:127\u2013138","journal-title":"Pharmacol Rep"},{"key":"1517_CR33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nrn2168","volume":"8","author":"FM LaFerla","year":"2007","unstructured":"LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-[beta] in Alzheimer\u2019s disease. Nat Rev Neurosci 8:499\u2013509","journal-title":"Nat Rev Neurosci"},{"issue":"Suppl 1","key":"1517_CR34","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1097\/00002093-200000001-00008","volume":"14","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Arai T, Kondo H, Tanno E, Haga C, Ikeda K (2000) Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis Assoc Disord 14(Suppl 1):S47\u2013S53","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1517_CR35","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci 12:383\u2013388","journal-title":"Trends Pharmacol Sci"},{"key":"1517_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0955-0674(00)00172-1","volume":"13","author":"ML Garcia","year":"2001","unstructured":"Garcia ML, Cleveland DW (2001) Going new places using an old MAP: tau, microtubules and human neurodegenerative disease. Curr Opin Cell Biol 13:41\u201348","journal-title":"Curr Opin Cell Biol"},{"key":"1517_CR37","first-page":"171","volume":"19","author":"MH Zhou","year":"1997","unstructured":"Zhou MH, Wu X, Chen S (1997) Distribution of MNTF1 in spinal cord and limb muscles of mice with motoneuron disease. Acta Acad Med Sin 19:171\u2013178","journal-title":"Acta Acad Med Sin"},{"key":"1517_CR38","first-page":"86","volume":"29","author":"X Di","year":"1997","unstructured":"Di X, Huang W (1997) Localization and morphometric study on motoneuronotrophic factor 1 and its receptor in developing chorionic villi of human placenta. Acta Anatomica Sin 29:86\u201389","journal-title":"Acta Anatomica Sin"},{"key":"1517_CR39","first-page":"404","volume":"28","author":"X Di","year":"1997","unstructured":"Di X, Huang WQ, Sun L (1997) Immunohistochemical localization of c-fos p53 protein & MNTF1 receptor in early human placental villi. Acta Anatomica Sin 28:404\u2013406","journal-title":"Acta Anatomica Sin"},{"key":"1517_CR40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.12688\/f1000research.10519.1","volume":"6","author":"M Kindy","year":"2017","unstructured":"Kindy M, Lupinacci P, Chau R, Shum T, Ko D (2017) A phase 2A randomized, double-blind, placebo-controlled pilot trial of GM604 in patients with amyotrophic lateral sclerosis (ALS protocol GALS-001) and a single compassionate patient treatment (protocol GALS-C). F1000 Res 6:230","journal-title":"F1000 Res"},{"key":"1517_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5599\/admet.544","volume":"6","author":"KL Valko","year":"2018","unstructured":"Valko KL, Kindy M, Evans J, Ko D (2018) In vitro biomimetic HPLC and in vivo characterisation of GM6, an endogenous regulator peptide drug candidate for amyotrophic lateral sclerosis. ADMET & DMPK 6:162\u2013175","journal-title":"ADMET & DMPK"},{"key":"1517_CR42","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.18632\/aging.101209","volume":"9","author":"J Yu","year":"2017","unstructured":"Yu J, Zhu H, Perry S, Taheri S, Kindy MS (2017) Daily supplementation with GrandFusion\u00ae improves memory and learning in aged rats. Aging 9:1041\u20131054","journal-title":"Aging"},{"key":"1517_CR43","first-page":"153","volume":"6","author":"KL Valko","year":"2018","unstructured":"Valko KL, Ivanova-Berndt G, Beswick P, Kindy M, Ko D (2018) Application of biomimetic HPLC to estimate lipophilicity, protein and phospholipid binding of potential peptide therapeutics. ADMET & DMPK 6:153\u2013161","journal-title":"ADMET & DMPK"},{"key":"1517_CR44","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1517\/13543780903066780","volume":"18","author":"BP Imbimbo","year":"2009","unstructured":"Imbimbo BP (2009) An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer\u2019s disease. Expert Opin Investig Drugs 18:1147\u20131168","journal-title":"Expert Opin Investig Drugs"},{"key":"1517_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JAD-160197","volume":"54","author":"I Olsen","year":"2016","unstructured":"Olsen I, Singhrao SK (2016) Inflammasome involvement in Alzheimer\u2019s disease. J Alzheimers Dis 54:45\u201353","journal-title":"J Alzheimers Dis"},{"key":"1517_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40035-018-0135-7","volume":"7","author":"WR Swindell","year":"2018","unstructured":"Swindell WR, Bojanowski K, Kindy MS, Chau RMW, Ko D (2018) GM604 regulates developmental neurogenesis pathways and the expression of genes associated with amyotrophic lateral sclerosis. Transl Neurodegener 7:30","journal-title":"Transl Neurodegener"}],"updated-by":[{"DOI":"10.1007\/s12035-019-1558-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T00:00:00Z","timestamp":1553299200000}}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1517-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-1517-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1517-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T13:48:28Z","timestamp":1589896108000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-1517-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,23]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1517"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-1517-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12035-019-1558-6","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,23]]},"assertion":[{"value":"15 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The name of author \u201cWilliam Swindell\u201d missed the midle initial \u201cR.\u201d. This should be written as \u201cWilliam R. Swindell\u201d as corrected above.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was approved by the IACUC of the University of South Florida, following the guidelines for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dorothy Ko is an employee of Genervon and has interest in the company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}